Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
significant threat » significant effect (Expand Search), significant increase (Expand Search), significant decrease (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
threat decrease » greater decrease (Expand Search), largest decrease (Expand Search)
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
significant threat » significant effect (Expand Search), significant increase (Expand Search), significant decrease (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
threat decrease » greater decrease (Expand Search), largest decrease (Expand Search)
-
101
-
102
Significant change in self-reported behaviour between Pre-Test (T1) to Follow-Up (T3).
Published 2019“…Significant decrease in the number of sweets consumed per day was identified. c) Instances of tobacco use reported at T1 and T3. …”
-
103
Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report
Published 2024“…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
-
104
-
105
-
106
-
107
Activities reported to impact SWB the most the past four weeks and Yesterday’s Activities.
Published 2022Subjects: -
108
-
109
-
110
-
111
-
112
-
113
-
114
Changes in reported rate of AEFIs in the pre-LAW and post-LAW period(/10000).
Published 2025Subjects: -
115
-
116
-
117
Effect of interventions on antimicrobial use (proportion of patients receiving antimicrobials).
Published 2023Subjects: -
118
-
119
-
120